研究者業績

坪井 直毅

ツボイ ナオタケ  (Naotake Tsuboi)

基本情報

所属
藤田医科大学 医学部腎臓内科学 教授
学位
医学博士(名古屋大学)

J-GLOBAL ID
201001034860762065
researchmap会員ID
1000314029

学歴

 2

委員歴

 1

受賞

 1

論文

 146
  • 毛受 大也, 小出 滋久, 林 宏樹, 長谷川 みどり, 高橋 和男, 湯澤 由紀夫, 藤垣 英嗣, 坪井 直毅
    日本腎臓学会誌 66(4) 594-594 2024年6月  
  • Ken-Ei Sada, Kenji Nagasaka, Shinya Kaname, Tomoaki Higuchi, Shunsuke Furuta, Toshihiro Nanki, Naotake Tsuboi, Koichi Amano, Hiroaki Dobashi, Keiju Hiromura, Masashi Bando, Takashi Wada, Yoshihiro Arimura, Hirofumi Makino, Masayoshi Harigai
    Modern rheumatology 34(3) 551-558 2024年3月28日  
    OBJECTIVE: This study aimed to evaluate the Ministry of Health, Labour and Welfare (MHLW) diagnostic criteria for antineutrophil cytoplasmic antibody-associated vasculitis compared to the new American College of Rheumatology/European Alliance of Associations for Rheumatology 2022 criteria. METHODS: Two nationwide cohort studies were used, and participants were categorised as having eosinophilic granulomatosis with polyangiitis, granulomatosis with polyangiitis (GPA), or microscopic polyangiitis (MPA) according to the American College of Rheumatology/European Alliance of Associations for Rheumatology 2022 and MHLW criteria. RESULTS: Of the entire patient population, only 10 (2.1%) were unclassifiable according to the MHLW probable criteria, while a significant number of patients (71.3%) met at least two criteria. The MHLW probable criteria for MPA had some challenges in differentiating between MPA and eosinophilic granulomatosis with polyangiitis, and the same was true for MHLW probable criteria for GPA in differentiating MPA from GPA. Nevertheless, improved classification results were obtained when the MHLW probable criteria were applied in the order of eosinophilic granulomatosis with polyangiitis, MPA, and GPA. CONCLUSIONS: The application of MHLW criteria could categorise a substantial number of patients with antineutrophil cytoplasmic antibody-associated vasculitis into one of the three antineutrophil cytoplasmic antibody-associated vasculitis diseases. The classification was in accordance with the American College of Rheumatology/European Alliance of Associations for Rheumatology 2022 criteria when considering the order of application.
  • Tomohiro Mizuno, Fumihiko Nagano, Kazuo Takahashi, Shigeki Yamada, Kazuhiro Fruhashi, Shoichi Maruyama, Naotake Tsuboi
    FEBS open bio 2024年2月15日  
    Acute lung injury (ALI), which occurs in association with sepsis, trauma, and coronavirus disease 2019 (COVID-19), is a serious clinical condition with high mortality. Excessive platelet-leukocyte aggregate (PLA) formation promotes neutrophil extracellular trap (NET) release and thrombosis, which are involved in various diseases, including ALI. Macrophage-1 antigen (Mac-1, CD11b/CD18), which is expressed on the surface of leukocytes, is known to promote NET formation. This study aimed to elucidate the role of Mac-1 in extracellular histone-induced ALI. Exogenous histones were administered to Mac-1-deficient mice and wild-type (WT) mice with or without neutrophil or platelet depletion, and several parameters were investigated 1 h after histone injection. Depletion of neutrophils or platelets improved survival time and macroscopic and microscopic properties of lung tissues, and decreased platelet-leukocyte formation and plasma myeloperoxidase levels. These improvements were also observed in Mac-1-/- mice. NET formation in Mac-1-/- bone marrow neutrophils (BMNs) was significantly lower than that in WT BMNs. In conclusion, our findings suggest that Mac-1 is associated with exacerbation of histone-induced ALI and the promotion of NET formation in the presence of activated platelets.
  • Daijo Inaguma, Yoshitaka Tatematsu, Naoki Okamoto, Soshiro Ogata, Hideki Kawai, Eiichi Watanabe, Yukio Yuzawa, Midori Hasegawa, Naotake Tsuboi
    BMJ open 14(1) e076962 2024年1月24日  
    INTRODUCTION: Coronary artery and heart valve calcification is a risk factor for cardiovascular death in haemodialysis patients, so calcification prevention should be started as early as possible. Treatment with concomitant calcimimetics and low-dose vitamin D receptor activators (VDRAs) is available, but not enough evidence has been obtained on the efficacy of this regimen, particularly in patients with short dialysis duration. Therefore, this study will evaluate the efficacy and safety of early intervention with upacicalcet, a calcimimetic used to prevent coronary artery calcification in this patient population. METHODS AND ANALYSIS: This multicentre, open-label, randomised, parallel-group controlled study will compare an early intervention group, which received upacicalcet and a low-dose VDRA, with a conventional therapy group, which received a VDRA. The primary endpoint is a change in log coronary artery calcium volume score from baseline to 52 weeks. The main inclusion criteria are as follows: (1) age 18 years or older; (2) dialysis is planned or dialysis duration is less than 60 months; (3) intact parathyroid hormone (PTH) >240 pg/mL or whole PTH level>140 pg/mL; (4) serum-corrected calcium≥8.4 mg/dL and (5) Agatston score >30. The main exclusion criteria are as follows: (1) history of parathyroid intervention or fracture in the past 12 weeks; (2) history of myocardial infarction, stroke or leg amputation in the past 12 weeks; (3) history of coronary angioplasty and (4) heart failure of New York Heart Association class III or worse. ETHICS AND DISSEMINATION: The study will comply with the Declaration of Helsinki and the Japanese Clinical Trials Act. The study protocol has been approved by the Fujita Health University Certified Review Board (file no. CR22-052). Written informed consent will be obtained from all participants. Study results will be presented in academic meetings and peer-reviewed academic journals. TRIAL REGISTRATION NUMBER: jRCTs041220126.
  • 大橋 篤, 中谷 直史, 堀 秀生, 長谷川 みどり, 坪井 直毅
    日本アフェレシス学会雑誌 42(Suppl.) 78-78 2023年10月  

MISC

 162
  • Florencia Rosetti, Naotake Tsuboi, Kan Chen, Hiroshi Nishi, Thomas Ernandez, Sanjeev Sethi, Kevin Croce, George Stavrakis, Jorge Alcocer-Varela, Diana Gomez-Martin, Nico van Rooijen, Vasileios C. Kyttaris, Andrew H. Lichtman, George C. Tsokos, Tanya N. Mayadas
    JOURNAL OF IMMUNOLOGY 189(7) 3714-3723 2012年10月  査読有り
    Systemic lupus erythematosus (SLE) is a chronic, multiorgan inflammatory autoimmune disorder associated with high levels of circulating autoantibodies and immune complexes. We report that passive transfer of human SLE sera into mice expressing the uniquely human Fc gamma RIIA and Fc gamma RIIIB on neutrophils induces lupus nephritis and in some cases arthritis only when the mice additionally lack the CD18 integrin, Mac-1. The prevailing view is that Mac-1 on macrophages is responsible for immune complex clearance. However, disease permitted by the absence of Mac-1 is not related to enhanced renal immune complex deposition or in situ C1q/C3 complement activation and proceeds even in the absence of macrophages. Instead, disease is associated with increased Fc gamma RIIA-induced neutrophil accumulation that is enabled by Mac-1 deficiency. Intravital microscopy in the cremasteric vasculature reveals that Mac-1 mitigates Fc gamma RIIA-dependent neutrophil recruitment in response to deposited immune complexes. Our results provide direct evidence that human SLE immune complexes are pathogenic, demonstrate that neutrophils are primary mediators of end organ damage in a novel humanized lupus mouse model, and identify Mac-1 regulation of Fc gamma RIIA-mediated neutrophil recruitment as a key step in development of target organ damage. The Journal of Immunology, 2012, 189: 3714-3723.
  • Veronica Azcutia, Michael Stefanidakis, Naotake Tsuboi, Tanya Mayadas, Kevin J. Croce, Daiju Fukuda, Masanori Aikawa, Gail Newton, Francis W. Luscinskas
    JOURNAL OF IMMUNOLOGY 189(5) 2553-2562 2012年9月  査読有り
    At sites of inflammation, endothelial adhesion molecules bind leukocytes and transmit signals required for transendothelial migration (TEM). We previously reported that adhesive interactions between endothelial cell CD47 and leukocyte signal regulatory protein gamma (SIRP gamma) regulate human T cell TEM. The role of endothelial CD47 in T cell TEM in vivo, however, has not been explored. In this study, CD47(-/-) mice showed reduced recruitment of blood T cells as well as neutrophils and monocytes in a dermal air pouch model of TNF-alpha-induced inflammation. Reconstitution of CD47(-/-) mice with wild-type bone marrow cells did not restore leukocyte recruitment to the air pouch, indicating a role for endothelial CD47. The defect in leukocyte TEM in the CD47(-/-) endothelium was corroborated by intravital microscopy of inflamed cremaster muscle microcirculation in bone marrow chimera mice. In an in vitro human system, CD47 on both HUVEC and T cells was required for TEM. Although previous studies showed CD47-dependent signaling required G(alpha i)-coupled pathways, this was not the case for endothelial CD47 because pertussis toxin, which inactivates G(alpha i), had no inhibitory effect, whereas G(alpha i) was required by the T cell for TEM. We next investigated the endothelial CD47-dependent signaling events that accompany leukocyte TEM. Ab-induced cross-linking of CD47 revealed robust actin cytoskeleton reorganization and Src- and Pyk-2-kinase dependent tyrosine phosphorylation of the vascular endothelial-cadherin cytoplasmic tail. This signaling was pertussis toxin insensitive, suggesting that endothelial CD47 signaling is independent of G(alpha i). These findings suggest that engagement of endothelial CD47 by its ligands triggers outside-in signals in endothelium that facilitate leukocyte TEM. The Journal of Immunology, 2012, 189: 2553-2562.
  • 平松 英樹, 伊藤 恭彦, 水野 正司, 鈴木 康弘, 戸田 晋, 坪井 直毅, 伊藤 功, 佐藤 和一, 丸山 彰一, 今井 圓裕, 林 裕樹, 松尾 清一
    腎と透析 73(別冊 腹膜透析2012) 235-236 2012年8月  
    腹膜透析(PD)における小・中・大分子量物質除去と腹膜機能との関連性について検討した。PD患者51例を対象とした。小分子量物質D/P ureaは、D/P Crに比し溶質透過性は高く、相関を認めた。腹膜平衡試験(PET)4時間値でD/P=1となった症倒も認めた。D/P CrとD/P phosphate、D/P β2-MGは極めて強い有意な相関を認めた。D/P Crと大分子量物質の相関については、D/P Crと比較するといずれも大分子量物質の透過性は、低かったが、D/P Alb、D/P Tf、D/P IgG、α2-MGすべてにおいて、D/P Crと有意な相関を認めた。膜透析における溶質透過牲について、PETによる腹膜機能の把握は重要で、D/P Crで中分子量物質のD/P β2-MGの予測ができる可能性が示唆された。
  • 武藤 玲子, 鬼無 洋, 小島 博, 勝野 敬之, 鈴木 康弘, 安田 香, 尾崎 武徳, 小杉 智規, 安田 宣成, 佐藤 和一, 坪井 直毅, 水野 正司, 伊藤 恭彦, 今井 圓裕, 丸山 彰一, 松尾 清一
    日本腎臓学会誌 54(6) 872-872 2012年8月  
  • Susumu Toda, Yasuhiko Ito, Masashi Mizuno, Yasuhiro Suzuki, Isao Ito, Hideki Hiramatsu, Takenori Ozaki, Naotake Tsuboi, Waichi Sato, Shoichi Maruyama, Enyu Imai, Seiichi Matsuo
    NEPHROLOGY DIALYSIS TRANSPLANTATION 27(6) 2511-2516 2012年6月  査読有り
    Background. Colonic diverticulitis is an important cause of polymicrobial peritonitis, which requires surgical treatment and cessation of peritoneal dialysis (PD). The aim of this study was to examine whether plain abdominal computed tomography (CT) is useful for evaluating colonic diverticulosis in chronic kidney disease (CKD) patients and to explore whether colonic diverticulosis is a risk factor for enteric peritonitis. Methods. The subjects consisted of 137 consecutive CKD patients (Stage 4 or 5) who were candidates for PD from February 2005 to November 2009. Abdominal CT without contrast media was performed in all PD candidates. Results. Diverticula of the colon were detected by plain CT in 57 cases (41.6%). The number of diverticula tended to increase with age. The most common site of involvement of diverticulosis was the ascending colon. In patients treated with PD, the incidence of peritonitis was higher in patients with diverticulosis than in those without diverticulosis (P = 0.004). However, only one episode of enteric peritonitis was observed among patients with diverticulosis. The presence of diverticulosis did not affect cumulative or technical survival. PD was not selected in four cases due to a high frequency of diverticula with episodes of abdominal pain. Two cases developed severe diverticulitis with peritonitis and underwent resection of the colon. Conclusions. Our study suggests that plain CT examination is useful for detecting diverticulosis in CKD patients. Silent diverticulosis is not a risk factor for enteric diverticulosis-related peritonitis. PD may be contraindicated in cases having frequent diverticulosis with episodes of lower abdominal pain.
  • Isao Ito, Yasuhiko Ito, Masashi Mizuno, Yasuhiro Suzuki, Kaoru Yasuda, Takenori Ozaki, Tomoki Kosugi, Yoshinari Yasuda, Waichi Sato, Naotake Tsuboi, Shoichi Maruyama, Enyu Imai, Seiichi Matsuo
    CLINICAL AND EXPERIMENTAL NEPHROLOGY 16(3) 490-494 2012年6月  査読有り
    Oxaliplatin is effective in advanced colorectal cancer and is known to have relatively few side effects, such as hemolysis and renal toxicity. We report a case of acute kidney injury (AKI) after treatment with a combination of oxaliplatin, folinic acid and 5-fluorouracil or capecitabine. The patient developed acute renal failure, hemolytic anemia and thrombocytopenia after the 34th course of chemotherapy including oxaliplatin. A positive direct antiglobulin test and detection of immunoglobulin G and complement C3b and C3d on erythrocytes suggested the diagnosis of immune-related severe intravascular hemolytic anemia. She was successfully treated and recovered using plasma exchange, corticosteroids and hemodialysis therapy. Only seven other cases of AKI associated with oxaliplatin use have been reported to date. As in this case, acute hemolysis due to autoimmune mechanisms and subsequent AKI occurred suddenly after frequent use of oxaliplatin in four of those cases. We should be aware that oxaliplatin may cause sudden life-threatening hemolysis by drug-induced antibodies and subsequent AKI, even though oxaliplatin is frequently administered without side effects. This represents the first case report of AKI-related hemolysis due to oxaliplatin in Japan.
  • 伊藤 功, 坂 まりえ, 野中 慶佑, 伊藤 裕紀子, 加納 康子, 勝野 敬之, 戸田 晋, 鈴木 康弘, 安田 香, 尾崎 武徳, 小杉 智規, 安田 宜成, 佐藤 和一, 坪井 直毅, 水野 正司, 丸山 彰一, 伊藤 恭彦, 今井 圓裕, 松尾 清一
    日本透析医学会雑誌 45(Suppl.1) 777-777 2012年5月  
  • 佐藤 和一, 丸山 彰一, 坪井 直毅, 春日 弘毅, 高橋 宏, 伊藤 恭彦, 今井 圓裕, 松尾 清一
    日本透析医学会雑誌 45(Suppl.1) 822-822 2012年5月  
  • 鈴木 康弘, 坂 まりえ, 野中 慶佑, 伊藤 裕紀子, 加納 康子, 勝野 敬之, 戸田 晋, 安田 香, 尾崎 武徳, 小杉 智規, 安田 宜成, 佐藤 和一, 坪井 直毅, 伊藤 功, 水野 正司, 今井 圓裕, 丸山 彰一, 伊藤 恭彦, 松尾 清一
    日本透析医学会雑誌 45(Suppl.1) 888-888 2012年5月  
  • 坪井 直毅, 坂 まりえ, 増田 智広, 加納 康子, 佐藤 和一, 丸山 彰一, 伊藤 恭彦, 今井 圓裕, 松尾 清一
    日本透析医学会雑誌 45(Suppl.1) 941-941 2012年5月  
  • 金 恒秀, 水野 正司, 古橋 和拡, 勝野 敬之, 安田 香, 尾崎 武徳, 坪井 直毅, 佐藤 和一, 今井 圓裕, 伊藤 恭彦, 松尾 清一, 丸山 彰一
    日本透析医学会雑誌 45(Suppl.1) 655-655 2012年5月  
  • 安田 香, 丸山 彰一, 佐藤 和一, 坪井 直毅, 伊藤 恭彦, 今井 圓裕, 松尾 清一
    日本腎臓学会誌 54(3) 220-220 2012年4月  
  • Yasuhiro Suzuki, Masashi Mizuno, Ryoko Nakashima, Hideki Hiramatsu, Susumu Toda, Waichi Sato, Naotake Tsuboi, Isao Ito, Shoichi Maruyama, Enyu Imai, Seiichi Matsuo, Yasuhiko Ito
    CLINICAL AND EXPERIMENTAL NEPHROLOGY 15(6) 962-965 2011年12月  査読有り
    We report a case of peritonitis resulting from colon perforation caused by ingestion of a rare foreign body in a patient on peritoneal dialysis (PD). A 72-year-old woman on PD was hospitalized with abdominal pain and cloudy PD fluid (PDF). Although conventional antibiotic therapy was started because of a diagnosis of infectious peritonitis, low-grade fever, abdominal pain and a high number of white blood cells in PDF persisted. On day 3, anaerobic bacteria were recognized on bacterial culture of PDF, suggesting a gastrointestinal etiology. During exploratory laparotomy, sigmoidal perforation by a piece of bamboo, probably resulting from ingestion of contaminated food, was found.
  • 金 恒秀, 水野 正司, 古橋 和拡, 勝野 敬之, 安田 香, 尾崎 武徳, 坪井 直毅, 伊藤 恭彦, 松尾 清一, 丸山 彰一
    補体シンポジウム講演集 48 52-53 2011年9月  
  • 安田 宜成, 鈴木 康弘, 尾崎 武徳, 小杉 智規, 佐藤 和一, 坪井 直毅, 伊藤 功, 水野 正司, 丸山 彰一, 今井 圓裕, 伊藤 恭彦, 湯澤 由紀夫, 松尾 清一
    日本腎臓学会誌 53(6) 803-803 2011年8月  
  • 伊藤 裕紀子, 坂 まりえ, 野中 慶佑, 勝野 敬之, 加納 康子, 戸田 晋, 鈴木 康弘, 尾崎 武徳, 小杉 智規, 佐藤 和一, 安田 宜成, 坪井 直毅, 伊藤 功, 水野 正司, 伊藤 恭彦, 今井 圓裕, 丸山 彰一, 松尾 清一
    日本腎臓学会誌 53(6) 803-803 2011年8月  
  • 野中 慶佑, 坂 まりえ, 伊藤 裕紀子, 勝野 敬之, 加納 康子, 戸田 晋, 鈴木 康弘, 尾崎 武徳, 小杉 智規, 佐藤 和一, 安田 宜成, 坪井 直毅, 伊藤 功, 水野 正司, 伊藤 恭彦, 今井 圓裕, 丸山 彰一, 松尾 清一
    日本腎臓学会誌 53(6) 827-827 2011年8月  
  • 安田 宜成, 鈴木 康弘, 尾崎 武徳, 小杉 智規, 佐藤 和一, 坪井 直毅, 伊藤 功, 水野 正司, 丸山 彰一, 今井 圓裕, 伊藤 恭彦, 湯澤 由紀夫, 松尾 清一
    日本腎臓学会誌 53(6) 919-919 2011年8月  
  • Kiyonari Kato, Tomoki Kosugi, Waichi Sato, Hanayo Arata-Kawai, Takenori Ozaki, Naotake Tsuboi, Isao Ito, Hideo Tawada, Yukio Yuzawa, Seiichi Matsuo, Kenji Kadomatsu, Shoichi Maruyama
    CLINICAL AND EXPERIMENTAL NEPHROLOGY 15(3) 346-354 2011年6月  査読有り
    Growth factor Midkine (MK), which expresses on endothelial cells and renal proximal tubules, has been implicated in inflammation-related kidney diseases such as ischemic reperfusion-induced tubulointerstitial injury and diabetic nephropathy. The biological actions of MK are elicited through its chemotactic activity and chemokine-driven inflammatory pathway. Post-infectious glomerulonephritis is caused by the deposition of immune complexes into glomeruli by infiltrating a number of inflammatory cells. Therefore, we investigated whether MK might be involved in the pathogenesis of acute glomerulonephritis. We induced endocapillary proliferative glomerulonephritis in 129/SV mice using intraperitoneal injections of a large amount of protein. In contrast to mice deficient in MK (Mdk (-/-)), Mdk (+/+) mice induced by protein overload demonstrated more diffuse cellular proliferation in the mesangial areas and capillary lumens, eventually leading to glomerular damage and tubulointerstitial injury. This pathological observation could be attributable to neutrophil infiltration through the chemotaxis and stimulation of the MK-macrophage inflammatory protein (MIP)-2 pathway, but appeared to be due to the MK-related immunoglobulin (Ig)G deposition and C3 activation. These findings are often seen in infectious-related glomerular injury. Furthermore, the profile of MK expression was strongly consistent with that of glomerular damage and tubulointersititial injury. This study might provide a new insight into understanding the deleterious role of MK in endocapillary proliferative glomerulonephritis induced by protein overload.
  • 戸田 晋, 伊藤 恭彦, 水野 正司, 鈴木 康弘, 平松 英樹, 尾崎 武徳, 小杉 智規, 佐藤 和一, 坪井 直毅, 伊藤 功, 丸山 彰一, 今井 圓裕, 松尾 清一
    日本腎臓学会誌 53(3) 362-362 2011年5月  
  • 平松 英樹, 伊藤 恭彦, 水野 正司, 鈴木 康弘, 戸田 晋, 坪井 直毅, 伊藤 功, 佐藤 和一, 丸山 彰一, 今井 圓裕, 林 裕樹, 松尾 清一
    日本透析医学会雑誌 44(Suppl.1) 407-407 2011年5月  
  • 中島 諒子, 野中 慶佑, 早崎 貴洋, 立松 美穂, 木村 敏樹, 鈴木 康弘, 戸田 晋, 尾崎 武徳, 小杉 智規, 佐藤 和一, 坪井 直毅, 水野 正司, 丸山 彰一, 伊藤 恭彦, 今井 圓裕, 松尾 清一
    日本透析医学会雑誌 44(Suppl.1) 475-475 2011年5月  
  • 早崎 貴洋, 中島 諒子, 野中 慶祐, 立松 美穂, 戸田 晋, 鈴木 康弘, 尾崎 武徳, 小杉 智規, 安田 宜成, 佐藤 和一, 坪井 直毅, 伊藤 功, 水野 正司, 今井 圓裕, 丸山 彰一, 伊藤 恭彦, 松尾 清一
    日本透析医学会雑誌 44(Suppl.1) 624-624 2011年5月  
  • 伊藤 功, 早崎 貴洋, 中島 諒子, 野中 慶佑, 立松 美穂, 鈴木 康弘, 戸田 晋, 尾崎 武徳, 小杉 智規, 安田 宜成, 佐藤 和一, 坪井 直毅, 水野 正司, 丸山 彰一, 伊藤 恭彦, 今井 圓裕, 松尾 清一
    日本透析医学会雑誌 44(Suppl.1) 586-586 2011年5月  
  • 立松 美穂, 野中 慶祐, 中島 諒子, 早崎 貴洋, 戸田 晋, 鈴木 康弘, 尾崎 武徳, 小杉 智規, 安田 宜成, 佐藤 和一, 坪井 直毅, 伊藤 功, 水野 正司, 今井 圓裕, 伊藤 恭彦, 丸山 彰一, 松尾 清一
    日本腎臓学会誌 53(3) 341-341 2011年5月  
  • 金 恒秀, 水野 正司, 清水 明日香, 阿部 智子, 古橋 和拡, 勝野 敬之, 尾崎 武徳, 坪井 直毅, 今井 圓裕, 伊藤 恭彦, 松尾 清一, 丸山 彰一
    日本腎臓学会誌 53(3) 388-388 2011年5月  
  • 伊藤 功, 早崎 貴洋, 中島 諒子, 野中 慶佑, 立松 美穂, 鈴木 康弘, 戸田 晋, 尾崎 武徳, 小杉 智規, 安田 宜成, 佐藤 和一, 坪井 直毅, 水野 正司, 丸山 彰一, 伊藤 恭彦, 今井 圓裕, 松尾 清一
    日本透析医学会雑誌 44(Suppl.1) 567-567 2011年5月  
  • Yosuke Saka, Kazuhiro Furuhashi, Takayuki Katsuno, Hangsoo Kim, Takenori Ozaki, Kenta Iwasaki, Masataka Haneda, Waichi Sato, Naotake Tsuboi, Yasuhiko Ito, Seiichi Matsuo, Takaaki Kobayashi, Shoichi Maruyama
    XENOTRANSPLANTATION 18(3) 196-208 2011年5月  査読有り
    Background: Although the immunomodulatory effects of mesenchymal stromal cells (MSC) on T cells have been elucidated, little is known about their effects on B cells. Recently, we have established a novel culture method for adipose-derived MSC (ASC) using low (2%) serum medium containing fibroblast growth factor-2. We showed that low serum-cultured ASC (LASC) was superior to high (20%) serum cultured ASC (HASC) when used in regenerative therapy. The aim of this study was to compare the action of LASC, HASC, and bone marrow-derived MSC (BM-MSC), on xenoantibody production by B cells. Methods: Adipose-derived mesenchymal stromal cells and BM-MSC were obtained from humans or F344 rats and expanded in a low-serum or a high-serum culture medium. Proliferation of human peripheral mononuclear cells (PBMC) or rat splenocytes was induced by phytohemagglutinin (PHA) or anti-IgM-antibody. These cells were then co-cultured with LASC, HASC, or BM-MSC, and cell proliferation was studied. Porcine red blood cells (pRBC) were intraperitoneally injected into Lewis rats, and LASC, HASC, or BM-MSC obtained from F344 rats were injected intravenously or intraperitoneally. The levels of antibodies (IgM and IgG) against pRBC were examined using flow cytometry. Results: Human LASC suppressed PBMC proliferation more effectively than human HASC. Human LASC suppressed both T-cell and B-cell proliferation when incubated with PHA (a T-cell stimulus). However, human LASC did not suppress B-cell proliferation after incubation with anti-IgM-antibody (a T-cell-independent stimulus). Rat LASC suppressed PHA-stimulated splenocyte proliferation more effectively than rat HASC or rat BM-MSC. In vivo studies showed that intravenous injection of rat LASC significantly reduced the levels of IgG antibodies against pRBC, while intravenous administration of the other two types of MSC (rat HASC or rat BM-MSC) or intraperitoneal administration of rat LASC did not impede IgG production. A significant number of LASC were observed in the spleen when injected intravenously while only a few LASC were observed when given intraperitoneally. Conclusions: Administration of LASC effectively impeded xenoantibody production by B cells through the inhibition of T-cell function, while HASC or BM-MSC showed less promising effects. These results suggest that intravenous injection of LASC may be useful in attenuating antibody-mediated rejection.
  • Tsuboi N, Ernandez T, Li X, Nishi H, Cullere X, Mekala D, Hazen M, Köhl J, Lee DM, Mayadas TN
    Arthritis & Rheumatism 63(2) 467-478 2011年2月  査読有り
  • Masashi Mizuno, Yasuhiko Ito, Takahiro Hayasaki, Yasuhiro Suzuki, Hideki Hiramatsu, Susumu Toda, Tomohiro Mizuno, Miho Tatematsu, Takenori Ozaki, Yoshinari Yasuda, Waichi Sato, Naotake Tsuboi, Isao Ito, Shoichi Maruyama, Enyu Imai, Seiichi Matsuo
    INTERNAL MEDICINE 50(16) 1719-1723 2011年  査読有り
    A 68-year-old man was admitted with acute renal failure caused by cholesterol embolization after undergoing carotid artery stenting. Hemodialysis therapy (HD) was immediately required because of uremia, using nafamostat mesilate as an anticoagulant for HD. However, blue toes and gangrene of the feet worsened. To prevent use of anticoagulants and stabilize BP, HD was changed to peritoneal dialysis (PD). After starting PD, blue toes and gangrene improved markedly. Residual renal function also partially recovered. Although BP was unstable during HD, stability of BP and avoidance of anticoagulants during PD therapy might have contributed to the good results.
  • Masashi Mizuno, Yasuhiko Ito, Tomohiro Masuda, Susumu Toda, Hideki Hiramatsu, Yasuhiro Suzuki, Takenori Ozaki, Yoshinari Yasuda, Isao Ito, Naotake Tsuboi, Waichi Sato, Shoichi Maruyama, Enyu Imai, Seiichi Matsuo
    INTERNAL MEDICINE 50(5) 471-474 2011年  査読有り
    A 54-year-old woman on peritoneal dialysis (PD) was hospitalized with peritonitis with a high body temperature, abdominal pain and cloudy peritoneal fluid. She progressively fell into septic-like shock within only 6 hours after onset. The causative bacteria were Streptococcus mitis (S. mitis), part of the normal flora of oral cavity, intestine, female genial tract and upper respiratory tract. S. mitis shows pathogenicity for diseases such as endocarditis, brain abscesses and sepsis in children with malignancy or transplantation. However, S. mitis rarely shows severe pathogenic responses in adults. We report herein a case of fulminant peritonitis caused by S. mitis in an adult PD patient.
  • 立松 美穂, 野中 慶祐, 中島 涼子, 早崎 貴洋, 戸田 晋, 鈴木 康弘, 尾崎 武徳, 小杉 智規, 安田 宜成, 佐藤 和一, 坪井 直毅, 伊藤 功, 水野 正司, 今井 圓裕, 伊藤 恭彦, 丸山 彰一, 松尾 清一
    日本腎臓学会誌 52(6) 808-808 2010年8月  
  • 佐藤 和一, 増田 智広, 尾崎 武徳, 安田 宜成, 小杉 智規, 坪井 直毅, 伊藤 功, 水野 正司, 今井 圓裕, 丸山 彰一, 伊藤 恭彦, 松尾 清一
    日本腎臓学会誌 52(6) 838-838 2010年8月  
  • 早崎 貴洋, 立松 美穂, 戸田 晋, 鈴木 康弘, 尾崎 武徳, 小杉 智規, 安田 宜成, 佐藤 和一, 坪井 直毅, 伊藤 功, 水野 正司, 今井 圓裕, 丸山 彰一, 伊藤 恭彦, 松尾 清一
    日本腎臓学会誌 52(6) 847-847 2010年8月  
  • 丸山 彰一, 金 恒秀, 古橋 和拡, 勝野 敬之, 坂 洋祐, 尾崎 武徳, 坪井 直毅, 小林 孝彰, 松尾 清一
    Inflammation and Regeneration 30(4) 342-342 2010年7月  
  • 古橋 和拡, 石川 英昭, 金 恒秀, 勝野 敬之, 坂 洋祐, 尾崎 武徳, 坪井 直毅, 佐藤 和一, 今井 圓裕, 伊藤 恭彦, 湯沢 由紀夫, 丸山 彰一, 松尾 清一
    日本腎臓学会誌 52(3) 312-312 2010年5月  
  • 平松 英樹, 伊藤 恭彦, 水野 正司, 伊藤 功, 坪井 直毅, 戸田 晋, 鈴木 康弘, 澤井 晶穂, 鬼無 洋, 湯澤 由紀夫, 松尾 清一
    日本透析医学会雑誌 43(Suppl.1) 377-377 2010年5月  
  • 丸山 彰一, 尾崎 武徳, 高橋 亮, 春日 弘毅, 高橋 宏, 安田 宜成, 坪井 直毅, 佐藤 和一, 伊藤 功, 今井 圓裕, 伊藤 恭彦, 湯澤 由紀夫, 松尾 清一
    日本透析医学会雑誌 43(Suppl.1) 439-439 2010年5月  
  • 増田 智広, 早崎 貴洋, 金澤 蓉子, 立松 美穂, 浜田 禅, 戸田 晋, 平松 英樹, 尾崎 武徳, 安田 宜成, 佐藤 和一, 坪井 直毅, 伊藤 功, 水野 正司, 丸山 彰一, 伊藤 恭彦, 今井 圓裕, 湯澤 由紀夫, 松尾 清一
    日本透析医学会雑誌 43(Suppl.1) 741-741 2010年5月  
  • 尾崎 武徳, 早崎 貴洋, 増田 智広, 立松 美穂, 戸田 晋, 佐藤 和一, 坪井 直毅, 伊藤 功, 水野 正司, 丸山 彰一, 伊藤 恭彦, 今井 圓裕, 湯澤 由紀夫, 松尾 清一
    日本腎臓学会誌 52(3) 400-400 2010年5月  
  • Tanya N. Mayadas, George C. Tsokos, Naotake Tsuboi
    CIRCULATION 120(20) 2012-2024 2009年11月  査読有り招待有り
  • Junichi Hirahashi, Keiichi Hishikawa, Shinya Kaname, Naotake Tsuboi, Yunmei Wang, Daniel I. Simon, George Stavrakis, Tatsuo Shimosawa, Ling Xiao, Yutaka Nagahama, Kazuo Suzuki, Toshiro Fujita, Tanya N. Mayadas
    CIRCULATION 120(13) 1255-U144 2009年9月  査読有り
    Background-Inflammation and thrombosis coexist in several disorders. Although it is recognized that leukocytes may induce a procoagulant state at sites of inflammation, the critical molecular determinants of this process remain largely unknown. Methods and Results-To examine mechanisms of inflammation-induced thrombosis, we developed a murine model of thrombotic glomerulonephritis (TGN), a known cause of acute renal failure in patients. This model, induced by lipopolysaccharide and antibody to the glomerular basement membrane, led to rapid glomerular neutrophil recruitment, thrombotic glomerular lesions with endothelial cell injury, and renal dysfunction. In mice immunodepleted of neutrophils or lacking the leukocyte-specific integrin Mac-1, neutrophil recruitment, endothelial injury, glomerular thrombosis, and acute renal failure were markedly attenuated despite the robust generation of renal cytokines. Neutrophil elastase is a likely effector of Mac-1 because its activity was reduced in Mac-1-deficient mice and the phenotype in mice deficient in Mac-1 or neutrophil elastase was similar. Platelets accumulated in glomerular capillaries within 4 hours of TGN before evidence of thrombosis. Platelet immunodepletion before TGN markedly exacerbated hematuria (hemorrhage), inflammation, and injury, whereas thrombocytopenic Mac-1-deficient mice remained resistant to disease, indicating that initial glomerular platelet deposition protects the vessel wall from neutrophil-mediated sequelae. The subsequent thrombosis relied on the interaction of Mac-1 on recruited neutrophils with glycoprotein Ib alpha on platelets as antibody-mediated disruption of this interaction attenuated TGN without affecting renal neutrophil accumulation. Conclusions-These observations establish Mac-1 on neutrophils as a critical molecular link between inflammation and thrombosis and suggest it as an attractive target for antithrombotic therapy. (Circulation. 2009;120:1255-1265.)
  • Takaaki Yaomura, Naotake Tsuboi, Yoshinori Urahama, Akinori Hobo, Kenji Sugimoto, Jun Miyoshi, Tetsuya Matsuguchi, Kannagi Reiji, Seiichi Matsuo, Yukio Yuzawa
    NEPHROLOGY 13(5) 397-404 2008年8月  査読有り
    Aim: Cot/Tpl2, a serine/threonine (Ser/Thr) protein kinase, has been classified as a member of the mitogen-activated protein kinase (MAPK) family, and is known to have a pleiotropic role. Many studies have reported the involvement of Cot/Tpl2, mainly as a member of the Toll-like receptor (TLR) 4 signalling pathway in lipopolysaccharide (LPS)-induced tumor necrosis factor-alpha (TNF-alpha) production. At the same time, it is also related to the caspase-dependent apoptotic pathway. Thus, the role of Cot/Tpl2 in ischaemia/reperfusion injury (IRI) in which TNF-alpha and apoptosis are the major pathogenetic factors was studied. Methods: IRI was induced in wild type (Cot/Tpl2(+/+)) mice and in Cot/Tpl2-deficient (Cot/Tpl2(-/-)) mice. The extent of tubular injury and renal function were studied. TNF-alpha production, neutrophil infiltration and apoptosis were also compared between the two groups. Results: Cot/Tpl2(-/-) mice had preserved renal function compared with wild type mice in IRI. Although Cot/Tpl2 was phosphorylated in IRI and in the cultured tubular epithelial cells (TEC) after stimulation with LPS and hydrogen peroxide, there were no significant differences in terms of TNF-alpha production, neutrophil infiltration or MAPK activation between Cot/Tpl2(+/+) and Cot/Tpl2(-/-) mice. In contrast, Cot/Tpl2(-/-) mice showed obviously reduced terminal deoxynucleotidyl transferase-mediated dUTP nick end labelling positive cells and cleaved caspase-3 positive cells. Furthermore, Cot/Tpl2-deficient TECs demonstrated significantly less caspase-3 activation after hydrogen peroxide stimulation with comparable caspase-9 activation to wild type TEC. Conclusion: Tpl2 did not function as a member of MAPK family, but as a promoter of apoptosis in IRI. These results suggest that Cot/Tpl2 could be a possible therapeutic target in IRI.
  • Naotake Tsuboi, Kenichi Asano, Michael Lauterbach, Tanya N. Mayadas
    IMMUNITY 28(6) 833-846 2008年6月  査読有り
    Inflammation mediated by anti body-antigen complexes contributes to autoimmune diseases. Mice deficient in the common Fc gamma-chain are protected from IgG-mediated glomerulonephritis and the reverse passive Arthus (RPA) reaction and FcR-bearing macrophages, and mast cells have been assigned primary roles in these processes. Here we demonstrate that neutrophil-selective transgenic expression of the two uniquely human neutrophil Fc gamma receptors (Fc gamma Rs), Fc gamma RIIA and Fc gamma RIIIB, in Fc gamma-chain-deficient mice restored susceptibility to progressive glomerulonephritis and the cutaneous RPA reaction. Fc gamma RIIIB and Fc gamma RIIA mediated neutrophil accumulation, whereas Fc gamma RIIA alone promoted organ injury. In a model of soluble immune complexes deposited within the vasculature, Fc gamma RIIIB was responsible for neutrophil slow rolling and adhesion whereas in the cremaster RPA, induced by both vascular and tissue soluble immune complexes, Fc gamma RIIA predominated. Thus, human Fc gamma Rs on neutrophils serve as molecular links between antibody and immunological disease, with Fc gamma RIIA promoting tissue injury and Fc gamma RIIIB and Fc gamma RIIA displaying specialized context-dependent functions in neutrophil recruitment.
  • Xavier Cullere, Michael Lauterbach, Naotake Tsuboi, Tanya N. Mayadas
    BLOOD 111(7) 3591-3598 2008年4月  査読有り
    Tissue-specific silencing of genes may be used for genetic engineering in mice and has possible therapeutic applications in humans. Current strategies in mice rely on Cre/IoxP technology requiring the generation of multiple transgenic lines and breeding strategies. Here, we describe the selective silencing of CD18, a leukocyte-specific integrin in neutrophils using a micro RNA(miRNA) strategy that requires the generation of one transgenic line. CD18-specific miRNA hairpin driven by the myeloid specific human MRP8 promoter resulted in the generation of transgenic lines with 75% to 95% reduction in CD18 protein levels in neutrophils and monocytes. Minimal decreases in T cells and a partial diminution in macrophages were observed. Neutrophil CD18 silencing resulted in neutrophilia, splenomegaly, and significant defects in neutrophil trafficking with the degree of alterations correlating with the extent of CD18 silencing. Thus, our data demonstrate the utility of using miRNA approaches to silence genes in neutrophils, which are terminally differentiated cells with a short half-life that largely pre- cludes their genetic manipulation in vitro. Furthermore, the mouse models provide a valuable tool to examine the contribution of CD18 on neutrophils to leukocyte adhesion deficiency type 1 (LAD-1), a complex inherited disorder in which reduced or absent CD18 expression in multiple leukocyte subsets leads to impaired innate and adaptive immune responses.
  • Julia Menke, Julie A. Lucas, Geraldine C. Zeller, Marv E. Keir, Xiao R. Huang, Naotake Tsuboi, Tanya N. Mayadas, Han Y. Lan, Arlene H. Sharpe, Vicki R. Kelley
    JOURNAL OF IMMUNOLOGY 179(11) 7466-7477 2007年12月  査読有り
    The programmed death 1/programmed death 1 ligand (PD-L) pathway is instrumental in peripheral tolerance. Blocking this pathway exacerbates experimental autoimmune diseases, but its role in autoimmune kidney disease has not been explored. Therefore, we tested the hypothesis that the programmed death 1 ligands (PD-L1 and PD-L2), provide a protective barrier during T cell-and macrophage (M phi)-dependent autoimmune kidney disease. For this purpose, we compared nephrotoxic serum nephritis (NSN) in mice lacking PD-L1 (PD-L1(-/-)), PD-L2 (PD-L2(-/-)), or both (PD-L1/L2(-/-)) to wild-type (WT) C57BL/6 mice. Kidney pathology, loss of renal function, and intrarenal leukocyte infiltrates were increased in each PD-L(-/-) strain as compared with WT mice. Although the magnitude of renal pathology was similar in PD-L1(-/-) and PD-L2-/- mice, our findings suggest that kidney disease in each strain is regulated by distinct mechanisms. Specifically, we detected increased CD68(+) cells along with elevated circulating IgG and IgG deposits in glomeruli in PD-L2(-/-) mice, but not PD-L1(-/-) mice. In contrast, we detected a rise in activated CD8(+) T cells in PD-L1(-/-) mice, but not PD-L2-/- mice. Furthermore, since PD-L1 is expressed by parenchymal and hemopoietic cells in WT kidneys, we explored the differential impact of PD-L1 expression on these cell types by inducing NSN in bone marrow chimeric mice. Our results indicate that PD-L1 expression on hemopoietic cells, and not parenchymal cells, is primarily responsible for limiting leukocyte infiltration during NSN. Taken together, our findings indicate that PD-L1 and PD-L2 provide distinct negative regulatory checkpoints poised to suppress autoimmune renal disease.
  • J. L. Young, K. Isoda, A. Zirlik, L. A. Macfarlane, N. Tsuboi, N. Gerdes, U. Schonbeck, P. Libby
    ATHEROSCLEROSIS SUPPLEMENTS 7(3) 168-168 2006年6月  
  • K Isoda, JL Young, A Zirlik, LA MacFarlane, N Tsuboi, N Gerdes, U Schonbeck, P Libby
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY 26(3) 611-617 2006年3月  査読有り
    Objective - Metformin may benefit the macrovascular complications of diabetes independently of its conventional hypoglycemic effects. Accumulating evidence suggests that inflammatory processes participate in type 2 diabetes and its atherothrombotic manifestations. Therefore, this study examined the potential action of metformin as an inhibitor of pro-inflammatory responses in human vascular smooth muscle cells ( SMCs), macrophages ( M phi s), and endothelial cells ( ECs). Methods and Results - Metformin dose-dependently inhibited IL-1 beta-induced release of the pro-inflammatory cytokines IL-6 and IL-8 in ECs, SMCs, and M phi s. Investigation of potential signaling pathways demonstrated that metformin diminished IL-1 beta-induced activation and nuclear translocation of nuclear factor-kappa B ( NF-kappa B) in SMCs. Furthermore, metformin suppressed IL-1 beta-induced activation of the pro-inflammatory phosphokinases Akt, p38, and Erk, but did not affect PI3 kinase ( PI3K) activity. To address the significance of the anti-inflammatory effects of a therapeutically relevant plasma concentration of metformin ( 20 mu mol/L), we conducted experiments in ECs treated with high glucose. Pretreatment with metformin also decreased phosphorylation of Akt and protein kinase C ( PKC) in ECs under these conditions. Conclusions - These data suggest that metformin can exert a direct vascular anti- inflammatory effect by inhibiting NF-kappa B through blockade of the PI3K-Akt pathway. The novel anti- inflammatory actions of metformin may explain in part the apparent clinical reduction by metformin of cardiovascular events not fully attributable to its hypoglycemic action.
  • K Sugimoto, M Ohata, J Miyoshi, H Ishizaki, N Tsuboi, A Masuda, Y Yoshikai, M Takamoto, K Sugane, S Matsuo, Y Shimada, T Matsuguchi
    JOURNAL OF CLINICAL INVESTIGATION 114(6) 857-866 2004年9月  査読有り
    A serine/threonine protein kinase, Cot/Tpl2, is indispensable for extracellular signal-regulated kinase (ERK) activation and production of TNF-alpha and PGE(2) in LPS-stimulated macrophages. We show here that Cot/Tpl2 is also activated by other Toll-like receptor (TLR) ligands. Bacterial DNA rich in the dinucleotide CG (CpG-DNA), unlike LPS or synthetic lipopeptide, activated ERK in a Cot/Tpl2-independent manner. Peritoneal macrophages and bone marrow-derived DCs from Cot/Tpl2(-/-) mice produced significantly more IL-12 in response to CpG-DNA than those from WT mice. Enhanced IL-12 production in Cot/Tpl2(-/-) macrophages is, at least partly, regulated at the transcriptional level, and the elevated IL-12 mRNA level in Cot/Tpl2(-/-) macrophages is accompanied by decreased amounts of IL-12 repressors, such as c-musculoaponeurotic fibrosarcoma. (c-Maf) and GATA sequence in the IL-12 promoter-binding protein (GA-12-binding protein; GAP-12) in the nucleus. Consistently, Cot/Tpl2(-/-) mice showed Th1-skewed antigen-specific immune responses upon OVA immunization and Leishmania major infection in vivo. These results indicate that Cot/Tpl2 is an important negative regulator of Th1-type adaptive immunity, that it achieves this regulation by inhibiting IL-12 production from accessory cells, and that it might be a potential target molecule in CpG-DNA-guided vaccination.
  • S Kato, Y Yuzawa, N Tsuboi, S Maruyama, Y Morita, T Matsuguchi, S Matsuo
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 15(5) 1289-1299 2004年5月  査読有り
    Acute peritonitis, in which peritoneal mesothelial cells are directly exposed to bacterial components, is a major cause of peritoneal dysfunction in continuous ambulatory peritoneal dialysis patients. We have previously shown that Toll-like receptors (TLR) are expressed in kidney cells, and LPS induces TLR4-dependent chemokine production in tubular epithelial cells. The present work was designed to investigate the involvement of TLR, especially TLR4, in the lipid A-mediated chemokine production by murine peritoneal mesothelial cells (MPMC). A primary cell culture of MPMC from C3H/HeN mice (wild-type mice; LPS sensitive) and from C3H/HeJ mice (containing a point mutation of TLR4; LPS hyposensitive) was established. The expression profile of the TLR family and their accessory molecules, CD14 and MD-2, which are requisite for the LPS signaling pathway, was examined by RT-PCR, Northern blot test, and immunohistochemical staining. Synthetic lipid A-mediated chemokine production by MPMC was studied. The involvement of MAP kinase family (ERK, JNK, and p38 mitogen-activated protein kinase) and nuclear factor (NF)-kappaB in these processes was also studied. MPMC constitutively express TLR4, CD14, and MD-2. A prominent induction of monocyte chemotactic protein-1 (MCP-1) and macrophage inflammatory protein (MIP)-2 by MPMC was detected after lipid A stimulation and was strictly dependent on TLR4. Furthermore, TLR4-dependent chemokine production followed by leukocyte influx into the peritoneal cavity was also confirmed in vivo after stimulation with LPS. mRNA expression of MCP-1 was abolished by NF-kappaB inhibition, but were not affected by the inhibition of ERK, JNK, or p38. As compared with MCP-1, MIP-2 mRNA expression was inhibited by a high dose of curcumin but not by NF-kappaB decoy oligodeoxynucleotide and individual inhibitions of MAP kinase, suggesting that the additional signaling pathway with NF-kappaB might be involved in mRNA expression of MIP-2. These show that TLR4 is directly involved in the production of MCP-1 and MIP-2 by MPMC in a NF-kappaB-dependent manner, but the process does not require any MAP kinase activation. The results provide a candidate molecular target in prevention of it.

書籍等出版物

 23

講演・口頭発表等

 12
  • 伊藤 辰将, 辰川 英樹, 梅田 良祐, 横江 優貴, 高橋 和男, 湯澤 由紀夫, 人見 清隆, 坪井 直毅
    日本腎臓学会誌 2021年6月 (一社)日本腎臓学会
  • 坪井 直毅, 横江 優貴, 北川 章充, 伊藤 辰将, 遠藤 信英, 丸山 彰一
    腎臓内科 2021年6月 (有)科学評論社
  • 細江 眞生, 森 万佑子, 鈴木 むつみ, 山田 幸恵, 新 典雄, 加藤 政雄, 大高 洋平, 長谷川 みどり, 坪井 直毅, 中井 滋
    日本透析医学会雑誌 2021年5月 (一社)日本透析医学会
  • 吉田 浩之, 湯澤 由紀夫, 長谷川 みどり, 稲熊 大城, 坪井 直毅, 林 宏樹, 小出 滋久, 大山 翔也, 多賀谷 知輝, 伊藤 辰将, 成宮 利幸, 磯貝 理恵子, 古田 弘貴, 堀内 雅人
    腎と透析 2020年8月 (株)東京医学社
  • Yuki Yokoe, Naotake Tsuboi, Takahiro Imaizumi, Akimitsu Kitagawa, Munetoshi Karasawa, Takaya Ozeki, Nobuhide Endo, Yuriko Sawa, Sawako Kato, Takayuki Katsuno, Shoichi Maruyama, Kunihiro Yamagata, Joichi Usui, Michio Nagata, Ken-Ei Sada, Hitoshi Sugiyama, Koichi Amano, Yoshihiro Arimura, Tatsuya Atsumi, Yukio Yuzawa, Hiroaki Dobashi, Yoshinari Takasaki, Masayoshi Harigai, Hitoshi Hasegawa, Hirofumi Makino, Seiichi Matsuo
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2020年7月8日
    BACKGROUND: The detection of leukocyte-derived CD11b (α subunit of integrin Mac-1) and CD163 (scavenger receptor) in urine may reflect renal inflammation in antineutrophil cytoplasmic antibody-associated glomerulonephritis (ANCA-GN). The objective of this study was to evaluate the clinical significance of urinary CD11b (U-CD11b) and CD163 (U-CD163) in ANCA-GN. METHODS: U-CD11b and U-CD163 were examined using enzyme-linked immunosorbent assay in ANCA-GN urine samples from our institutional cohort (n = 88) and a nationwide cohort (n = 138), and their association with renal histology was subsequently analyzed. Logistic regression analyses were performed on a nationwide ANCA cohort to determine the associations of the two urinary molecules with renal remission failure at 6 months or with yearly estimated glomerular filtration rate (eGFR) slope over a 24-month observation period. RESULTS: U-CD11b and U-CD163 were significantly associated with cellular crescent formation and leukocyte accumulation in glomerular crescents. With regard to interstitial inflammation, both levels of U-CD11b and U-CD163 at diagnosis remarkably increased in ANCA-GN compared with the levels observed in nonglomerular kidney disorders including nephrosclerosis, immunoglobulin G4-related disease and tubulointerstitial nephritis; however, the presence of U-CD11b alone was significantly correlated with tubulointerstitial leukocyte infiltrates. Although neither U-CD11b nor U-CD163 at diagnosis was associated with remission failure at 6 months, multivariate analysis demonstrated that the baseline U-CD11b levels were significantly associated with the increase in eGFR following immunosuppressive therapy. CONCLUSIONS: Although both U-CD11b and U-CD163 reflect renal leukocyte accumulation, U-CD11b at diagnosis provides additional clinical value by predicting the recovery rate after the treatment of ANCA-GN.

担当経験のある科目(授業)

 2

共同研究・競争的資金等の研究課題

 13